Drug Shortage Report for ACT BORTEZOMIB

Last updated on 2025-01-23 History
Report ID 248442
Drug Identification Number 02438399
Brand name ACT BORTEZOMIB
Common or Proper name BORTEZUMIB AT 3.5MG IJP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BORTEZOMIB
Strength(s) 3.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1
ATC code L01XG
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-01-20
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-01-23
Company comments Item is on susp supply
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2025-01-23 French Compare
v1 2025-01-23 English Compare

Showing 1 to 2 of 2